Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InSaKa Trial: Insulin Dextrose vs Salbutamol vs Combination in Acute Hyperkalemia
NCT04012138Phase 4Completed
- Sponsor
- CHU de Nantes
- Start
- Dec 2019
- Primary completion
- Dec 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salbutamol, insulin aspart in hyperkalemia, sponsored by CHU de Nantes. Started Dec 2019; status: completed.
02
Drugs
salbutamolinsulin aspart
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT04012138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04012138.